• Led a 20 people COVID-19 task force which oversaw the product development and end to end management of COVID-19 related supplies with a daily production capacity of 25k liters sanitizer and 15k masks.• Collaborated with Government of India for supply of COVID-19 essentials as aid for Nepal and Bhutan in 2020.• Revamped the product portfolio, based on a cost & revenue analysis, yielding a 6% increase in profit.• Supervised the organization of industry specific business exhibitions (iPHEX and CPHi) in 2017 and 2018 with a client conversion rate of 23% (against an industry average of 12%).

• Established the company’s export division by registering products in EMEA region leading to additional annual revenue of $3M.• Achieved 200% increase in business with private sector clients by onboarding 16 new clients, improving the profit margin by 15% while reducing the average payment cycle by 33%.• Signed a long-term contract worth $10M with the Ministry of Defense, India in 2019 for a customized mosquito repellent addressing a large demand supply gap. • Conceptualized and promoted climate friendly airless medicated sprays with government counterparties, earning ~ 20k carbon credits.

• Achieved 1.5x of my sales target by onboarding 14 new clients over 2 years for additional annual revenue of ~$1M• Pioneered the bundling of technical training workshops with sales contract which helped in gaining 5 clients from competition leading to an additional revenue of $300k for the company.• Negotiated 10-year contracts with portfolio clients by providing signing discounts, annual training camps and other ancillary services, leading to cumulative revenue of $11M.• Conducted & presented a detailed demand supply analysis for a tier 2 city enabling the establishment of a supply chain hub in that city and an additional $500k annual revenue for the company.• Assisted in overhauling the product mix by conducting a product level profitability analysis which enabled us to identify and phase out potential loss-making product, improving the profit margin by 4%.• Developed a 5-year sales plan forecasting a 20% increase in revenue for the healthcare gases division, supported by secondary market research on new target regions.